Reduced GLT1 protein levels have been observed in patients diagnosed with Huntington’s Disease (HD) or Amyotrophic Lateral Sclerosis (ALS), as well as in several animal models of these NDDs12–16. The gene discussed is SLC1A2; the disease is Huntington disease.